Pfizer (PFE): Declines in COVID-19 products expected to drag down overall revenue in 2023
Shares of Pfizer Inc. (NYSE: PFE) were down on Tuesday despite the company delivering better-than-expected results for the first quarter of 2023. The stock has dropped 24% year-to-date. The company […]
The post Pfizer (PFE): Declines in COVID-19 products expected to drag down overall revenue in 2023 first appeared on AlphaStreet.